Vestor Capital LLC Cuts Stake in Cardinal Health, Inc. (NYSE:CAH)

Vestor Capital LLC cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 46.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 84,680 shares of the company's stock after selling 73,828 shares during the quarter. Vestor Capital LLC's holdings in Cardinal Health were worth $10,015,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. OneDigital Investment Advisors LLC grew its stake in Cardinal Health by 9.0% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 3,732 shares of the company's stock valued at $412,000 after acquiring an additional 307 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Cardinal Health by 23.9% during the third quarter. Thrivent Financial for Lutherans now owns 12,727 shares of the company's stock worth $1,406,000 after purchasing an additional 2,451 shares in the last quarter. Prospera Financial Services Inc purchased a new position in Cardinal Health in the 3rd quarter valued at about $214,000. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Cardinal Health in the 3rd quarter worth about $1,280,000. Finally, PNC Financial Services Group Inc. boosted its holdings in Cardinal Health by 2.1% in the 3rd quarter. PNC Financial Services Group Inc. now owns 72,702 shares of the company's stock worth $8,035,000 after buying an additional 1,528 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Up 0.9 %

NYSE CAH traded up $1.16 during trading hours on Wednesday, reaching $133.91. The company had a trading volume of 1,231,981 shares, compared to its average volume of 1,972,162. The stock has a market capitalization of $32.35 billion, a P/E ratio of 24.98, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The stock has a 50-day moving average of $127.96 and a 200 day moving average of $120.48. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $134.74.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.51%. Cardinal Health's dividend payout ratio is currently 37.69%.

Analysts Set New Price Targets

CAH has been the topic of several research reports. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. raised their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Argus set a $148.00 target price on shares of Cardinal Health in a report on Tuesday, February 4th. Mizuho assumed coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price target on the stock. Finally, Wells Fargo & Company upped their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average price target of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.